Affordable Access

Access to the full text

The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma

Authors
  • Piber, Petra1
  • Vavpetic, Neza1
  • Goricar, Katja2
  • Dolzan, Vita2
  • Kovac, Viljem1, 3
  • Franko, Alenka1, 4
  • 1 Faculty of Medicine, University of Ljubljana, Slovenia , (Slovenia)
  • 2 Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Slovenia , (Slovenia)
  • 3 Institute of Oncology Ljubljana, Slovenia , (Slovenia)
  • 4 Clinical Institute of Occupational Medicine, University Medical Centre Ljubljana, Slovenia , (Slovenia)
Type
Published Article
Journal
Radiology and Oncology
Publisher
Sciendo
Publication Date
Oct 21, 2020
Volume
54
Issue
4
Pages
429–436
Identifiers
DOI: 10.2478/raon-2020-0057
Source
De Gruyter
Keywords
License
Green

Abstract

Background Asbestos exposure is associated with the development of pleural plaques as well as malignant mesothelioma (MM). Asbestos fibres activate macrophages, leading to the release of inflammatory mediators including interleukin 1 beta (IL-1β). The expression of IL-1β may be influenced by genetic variability of IL1B gene or regulatory microRNAs (miRNAs). This study investigated the effect of polymorphisms in IL1B and MIR146A genes on the risk of developing pleural plaques and MM. Subjects and methods In total, 394 patients with pleural plaques, 277 patients with MM, and 175 healthy control subjects were genotyped for IL1B and MIR146A polymorphisms. Logistic regression was used in statistical analysis. Results We found no association between MIR146A and IL1B genotypes, and the risk of pleural plaques. MIR146A rs2910164 was significantly associated with a decreased risk of MM (OR = 0.31, 95% CI = 0.13–0.73, p = 0.008). Carriers of two polymorphic alleles had a lower risk of developing MM, even after adjustment for gender and age (OR = 0.34, 95% CI = 0.14–0.85, p = 0.020). Among patients with known asbestos exposure, carriers of at least one polymorphic IL1B rs1143623 allele also had a lower risk of MM in multivariable analysis (OR = 0.50, 95% CI = 0.28–0.92, p = 0.025). The interaction between IL1B rs1143623 and IL1B rs1071676 was significantly associated with an increased risk of MM (p = 0.050). Conclusions Our findings suggest that genetic variability of inflammatory mediator IL-1β could contribute to the risk of developing MM, but not pleural plaques.

Report this publication

Statistics

Seen <100 times